ELIXF (Elixxer) Current Accrued Expense: $0.90 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Elixxer Current Accrued Expense?

Elixxer ELIXF Current Accrued Expense is $0.90 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Elixxer's Current Accrued Expense for the quarter that ended in Dec. 2025 was $0.90 Mil.

Elixxer's quarterly Current Accrued Expense declined from Jun. 2025 ($2.39 Mil) to Sep. 2025 ($2.36 Mil) and declined from Sep. 2025 ($2.36 Mil) to Dec. 2025 ($0.90 Mil).

Elixxer's annual Current Accrued Expense increased from Dec. 2023 ($2.05 Mil) to Dec. 2024 ($2.33 Mil) but then declined from Dec. 2024 ($2.33 Mil) to Dec. 2025 ($0.90 Mil).

Elixxer Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Elixxer's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer Current Accrued Expense Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.49 2.12 2.05 2.33 0.90

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.33 2.33 2.39 2.36 0.90

Elixxer Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.90 Mil mean?
Elixxer (ELIXF) has a Current Accrued Expense of $0.90 Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Elixxer and its competitors.
Is Elixxer's Current Accrued Expense too high?
Elixxer's current Current Accrued Expense is $0.90 Mil.
How does Elixxer's Current Accrued Expense compare to ZTS?
Elixxer's Current Accrued Expense of $0.90 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Elixxer and its competitors. Elixxer's current Current Accrued Expense is $0.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixxer stock overvalued right now?
Elixxer (ELIXF) has a current Current Accrued Expense of $0.90 Mil. The current Current Accrued Expense is $0.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Elixxer (ELIXF), the current Current Accrued Expense is $0.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.